{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"primary-triglyceride-deposit-cardiomyovasculopathy","columns":[{"gene":"","key":"population-89c1b7b911ec9cbd556f","label":"Primary triglyceride deposit cardiomyovasculopathy","mondoId":"MONDO:0035423","onsetQualifier":null,"originColumnKey":"MONDO:0035423/ORPHA:565612","originalViews":[{"key":"MONDO:0035423/ORPHA:565612","label":"Primary triglyceride deposit cardiomyovasculopathy","scopeLabel":"ORPHA:565612","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0cafd8ab99100c85541e6867e514b27218e2486338baee73a5efb06acd450ed0","0fd6eed0e59e8cb092a69dfa214cc2515d0bac0bd0b6f8401aba23276377da07","161cde369557ac9aae36b933e5e3dcdace1b9c466f33b46032bff39399a836a1","2743cec048498e85292317f7703133cedfe2dce238cab20b6311bc37e0e13970","2c509ea2a70c140fca492e2731eb2b92d4fb31b43e87bf26ae8141a984fe9de0","337d7820e71c5c07056030cee19b93f44b3962a8900a5a5d25a0c61284e97029","3f3378c801d2b0f6af530ba6864a010f24ab13ad81fd068632be98d54cb80c14","450563e007fa208e2c677b7309ce52229d596881bc73a507243f00e5d30f10e8","4539624aa6aee137076bc47867b4dc8ffcfbb8930a5746d0e52e0178db934c6c","4eee84cbfca8e552ad6e621b65030aa8290f1d6da14642d03ab12bdd17d93b2f","5b7fa30c041656f8e97236b09452969c736d852a082c3bbde2cb0018d6c8d6d8","60d4f71c865fa95529d8f69c46ece9150b2178d2ef374c9df7da7162ca38e962","65a515f7e07c92d55def851b590cd27d46a82604e14bdccb01d45541e3928950","6bfa2b1392e0f5eb1ce1ad4291f5a12f0c1cdb6be76355b6b29986fddf0c3f88","6fe41932a9feb0e6fb6633638cfab3e7c8fcec5620df0e17b4b1b11d9122ad55","7912856d156ea4b4ea73b739332cd2b2a528163477aa8c381023bade86df8d4d","8009a703a98bc618016b4ead56323e4ab834edaaafd2343a5fd4c78807f247d4","84c5ac337fdfed193eb698ee04460e752a5c0a02e092285a7617ceb49a0ac049","987b3c4dc401e148a4d6b1e79622e3b8525955d43fdec20beb06abf912604a4d","9953c6c2cc9e166dd4fb2c9ebb7f09b4146ee65c38ba6ee5558c66a9e99776c4","a9f96575934fcd382178ec13fcfe2d495ca7fa35b85290a68f546384b25e0a47","b3b2af8a24dea445b6fe7d362fc5665bbd85e03dedeeaed6e3e79a7591ecf215","ba7caa85dfe114fe1fad70cfdee42d118de11d2f13f6b59f97a83c453b4504d4","c070a188417a7245b43af7a77887a92926e1bc424f26e0d2af05e0b850662701","c5003a349fbc37a11918a3669e0b92122a92de67597e6c7b481847edac9aedf9","d4fb6be7179157cda399af7ea93c8225148b4c93429ae06c486d489feccb97cf","d5fed94bf0ba28c702ef7385f578dc8c9f2ff72b0c15235c342e11994e68a65f","e9f8ede3fa13dcf05d02b8b5197ac4c54eb7a97a22e3459c18e3fc9f0ad47e84","f7bc8c74abca60f75d5712f8f8b2b59c87258a026018f34aa65e1a5328ae8c1b"],"recordQualifiers":{},"scopeLabel":"ORPHA:565612","sourceIds":["ORPHA:565612"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-89c1b7b911ec9cbd556f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001430","HP:0031331","HP:0012379","HP:0000478","HP:0001435","HP:0001681","HP:0011675"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":29,"sourceGroups":{"orphanet":29}},"features":[{"hpoId":"HP:0001430","label":"Abnormal calf musculature morphology","primary":true},{"hpoId":"HP:0031331","label":"Abnormal cardiomyocyte morphology","primary":true},{"hpoId":"HP:0012379","label":"Abnormal circulating enzyme concentration or activity","primary":true},{"hpoId":"HP:0000478","label":"Abnormality of the eye","primary":true},{"hpoId":"HP:0001435","label":"Abnormality of the shoulder girdle musculature","primary":true},{"hpoId":"HP:0001681","label":"Angina pectoris","primary":true},{"hpoId":"HP:0011675","label":"Arrhythmia","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":false},{"hpoId":"HP:0001677","label":"Coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0005145","label":"Coronary artery stenosis","primary":false},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":false},{"hpoId":"HP:0002094","label":"Dyspnea","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":false},{"hpoId":"HP:0008064","label":"Ichthyosis","primary":false},{"hpoId":"HP:0009058","label":"Increased muscle lipid content","primary":false},{"hpoId":"HP:0011123","label":"Inflammatory abnormality of the skin","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0009805","label":"Low-output congestive heart failure","primary":false},{"hpoId":"HP:0001962","label":"Palpitations","primary":false},{"hpoId":"HP:0001733","label":"Pancreatitis","primary":false},{"hpoId":"HP:0032141","label":"Precordial pain","primary":false},{"hpoId":"HP:0031684","label":"Renal artery atherosclerosis","primary":false},{"hpoId":"HP:0003805","label":"Rimmed vacuoles","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0003756","label":"Skeletal myopathy","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0001922","label":"Vacuolated lymphocytes","primary":false}],"ledeHtml":"A rare inborn error of metabolism characterized by massive accumulation of triglycerides in the myocardium and coronary arteries, while plasma triglyceride levels are normal. Patients present in adulthood with signs and symptoms of coronary artery disease and severe heart failure. Concomitant skeletal myopathy is common. Vacuole formation in polymorphonuclear leukocytes is typically observed.","mondoId":"MONDO:0035423","node":{"canonicalSlug":"primary-triglyceride-deposit-cardiomyovasculopathy","comparisons":[{"documentSha256":"62bec1d2adf8fcaff39672333525c4fec5d269eb2a3f264448b8ac75a3b66eae","key":"legacy-triglyceride-deposit-cardiomyovasculopathy","kind":"legacy","label":"triglyceride deposit cardiomyovasculopathy","memberIds":["MONDO:0035423","MONDO:0979259"],"mondoId":"MONDO:0979259","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/triglyceride-deposit-cardiomyovasculopathy.62bec1d2adf8fcaff39672333525c4fec5d269eb2a3f264448b8ac75a3b66eae.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"primary triglyceride deposit cardiomyovasculopathy","paragraphs":["A rare inborn error of metabolism characterized by massive accumulation of triglycerides in the myocardium and coronary arteries, while plasma triglyceride levels are normal. Patients present in adulthood with signs and symptoms of coronary artery disease and severe heart failure. Concomitant skeletal myopathy is common. Vacuole formation in polymorphonuclear leukocytes is typically observed."],"scope":"exact","source":"MONDO","upstream":"Orphanet:565612","url":"https://monarchinitiative.org/MONDO:0035423"},"ownColumnKeys":["population-89c1b7b911ec9cbd556f"],"publication":"published","relationships":[{"kind":"parent","label":"triglyceride deposit cardiomyovasculopathy","mondoId":"MONDO:0979259","slug":"triglyceride-deposit-cardiomyovasculopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/22267"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"0cafd8ab99100c85541e6867e514b27218e2486338baee73a5efb06acd450ed0","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0032141","is_excluded":false,"label":"Precordial pain","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0fd6eed0e59e8cb092a69dfa214cc2515d0bac0bd0b6f8401aba23276377da07","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003805","is_excluded":false,"label":"Rimmed vacuoles","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"161cde369557ac9aae36b933e5e3dcdace1b9c466f33b46032bff39399a836a1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2743cec048498e85292317f7703133cedfe2dce238cab20b6311bc37e0e13970","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001430","is_excluded":false,"label":"Abnormal calf musculature morphology","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2c509ea2a70c140fca492e2731eb2b92d4fb31b43e87bf26ae8141a984fe9de0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001435","is_excluded":false,"label":"Abnormality of the shoulder girdle musculature","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"337d7820e71c5c07056030cee19b93f44b3962a8900a5a5d25a0c61284e97029","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3f3378c801d2b0f6af530ba6864a010f24ab13ad81fd068632be98d54cb80c14","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031684","is_excluded":false,"label":"Renal artery atherosclerosis","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"450563e007fa208e2c677b7309ce52229d596881bc73a507243f00e5d30f10e8","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0031331","is_excluded":false,"label":"Abnormal cardiomyocyte morphology","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4539624aa6aee137076bc47867b4dc8ffcfbb8930a5746d0e52e0178db934c6c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001677","is_excluded":false,"label":"Coronary artery atherosclerosis","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4eee84cbfca8e552ad6e621b65030aa8290f1d6da14642d03ab12bdd17d93b2f","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011123","is_excluded":false,"label":"Inflammatory abnormality of the skin","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5b7fa30c041656f8e97236b09452969c736d852a082c3bbde2cb0018d6c8d6d8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"60d4f71c865fa95529d8f69c46ece9150b2178d2ef374c9df7da7162ca38e962","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003077","is_excluded":false,"label":"Hyperlipidemia","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"65a515f7e07c92d55def851b590cd27d46a82604e14bdccb01d45541e3928950","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6bfa2b1392e0f5eb1ce1ad4291f5a12f0c1cdb6be76355b6b29986fddf0c3f88","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008064","is_excluded":true,"label":"Ichthyosis","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6fe41932a9feb0e6fb6633638cfab3e7c8fcec5620df0e17b4b1b11d9122ad55","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000478","is_excluded":false,"label":"Abnormality of the eye","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7912856d156ea4b4ea73b739332cd2b2a528163477aa8c381023bade86df8d4d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001962","is_excluded":false,"label":"Palpitations","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8009a703a98bc618016b4ead56323e4ab834edaaafd2343a5fd4c78807f247d4","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001681","is_excluded":false,"label":"Angina pectoris","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84c5ac337fdfed193eb698ee04460e752a5c0a02e092285a7617ceb49a0ac049","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"987b3c4dc401e148a4d6b1e79622e3b8525955d43fdec20beb06abf912604a4d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005145","is_excluded":false,"label":"Coronary artery stenosis","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9953c6c2cc9e166dd4fb2c9ebb7f09b4146ee65c38ba6ee5558c66a9e99776c4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003756","is_excluded":false,"label":"Skeletal myopathy","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a9f96575934fcd382178ec13fcfe2d495ca7fa35b85290a68f546384b25e0a47","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009058","is_excluded":false,"label":"Increased muscle lipid content","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3b2af8a24dea445b6fe7d362fc5665bbd85e03dedeeaed6e3e79a7591ecf215","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002094","is_excluded":false,"label":"Dyspnea","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba7caa85dfe114fe1fad70cfdee42d118de11d2f13f6b59f97a83c453b4504d4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001922","is_excluded":false,"label":"Vacuolated lymphocytes","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c070a188417a7245b43af7a77887a92926e1bc424f26e0d2af05e0b850662701","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5003a349fbc37a11918a3669e0b92122a92de67597e6c7b481847edac9aedf9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009805","is_excluded":false,"label":"Low-output congestive heart failure","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4fb6be7179157cda399af7ea93c8225148b4c93429ae06c486d489feccb97cf","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011675","is_excluded":false,"label":"Arrhythmia","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5fed94bf0ba28c702ef7385f578dc8c9f2ff72b0c15235c342e11994e68a65f","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9f8ede3fa13dcf05d02b8b5197ac4c54eb7a97a22e3459c18e3fc9f0ad47e84","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012379","is_excluded":false,"label":"Abnormal circulating enzyme concentration or activity","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f7bc8c74abca60f75d5712f8f8b2b59c87258a026018f34aa65e1a5328ae8c1b","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:565612","disease_name":"Primary triglyceride deposit cardiomyovasculopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:565612","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0035423\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:565612</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare inborn error of metabolism characterized by massive accumulation of triglycerides in the myocardium and coronary arteries, while plasma triglyceride levels are normal. Patients present in adulthood with signs and symptoms of coronary artery disease and severe heart failure. Concomitant skeletal myopathy is common. Vacuole formation in polymorphonuclear leukocytes is typically observed.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0035423\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"primary-triglyceride-deposit-cardiomyovasculopathy","sourceDocuments":[{"name":"MONDO: primary triglyceride deposit cardiomyovasculopathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0035423"}],"sourceNote":"","synonyms":["P-TGCV","primary neutral lipid storage disease with severe cardiovascular involvement"],"takeawayHtml":"","title":"primary triglyceride deposit cardiomyovasculopathy"},"schemaVersion":1}
